BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6938125)

  • 1. Terminal deoxynucleotidyl transferase-positive lymphadenopathy in acute-phase chronic granulocytic leukemia.
    Chillar RK; Wolf JL; Bearman RM; Teplitz RL
    Am J Clin Pathol; 1981 Mar; 75(3):403-6. PubMed ID: 6938125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the blastic crisis with terminal deoxynucleotidyl transferase positive blasts in chronic granulocytic leukemia.
    Sawada H; Tashima M; Konishi H; Usui T; Kita K; Oguma S; Kamada N; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):872-80. PubMed ID: 6949433
    [No Abstract]   [Full Text] [Related]  

  • 3. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy.
    Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K
    Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
    Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
    Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
    Paciucci PA; Keaveney C; Cuttner J; Holland JF
    Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminal deoxynucleotidyl transferase activity in non-hematologic and hematologic neoplasms.
    Castella A; Davey FR; Kurec AS; Thompson NA
    Ann Clin Lab Sci; 1982; 12(5):403-7. PubMed ID: 6958214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Ph1-positive chronic myeloid leukemia blast crisis with a high level of terminal deoxynucleotidyl transferase responded to vincristine and prednisolone therapy (author's transl)].
    Nagai K; Nesumi N; Higashida M; Nagata I; Ueshima Y; Sawada H; Uchino H
    Rinsho Ketsueki; 1979 Sep; 20(9):1154-61. PubMed ID: 292803
    [No Abstract]   [Full Text] [Related]  

  • 8. Enrichment of cell populations containing terminal deoxynucleotidyl transferase activity by free flow electrophoresis.
    Sarin PS; Virmani M; Gallo RC
    Int J Cancer; 1982 May; 29(5):501-6. PubMed ID: 6954135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoalkaline phosphatase labeling of terminal transferase in hematologic samples.
    Erber WN; Mason DY
    Am J Clin Pathol; 1987 Jul; 88(1):43-50. PubMed ID: 3300265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of terminal transferase in paraffin sections with the immunoperoxidase technique.
    Halverson CA; Falini B; Taylor CR; Parker JW
    Am J Pathol; 1981 Dec; 105(3):241-54. PubMed ID: 7032307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic changes in a case of blast crisis of CML: characterization by TdT, cytochemistry, and cytogenetics.
    Paietta E; Schwarzmeier JD
    Scand J Haematol; 1981 Oct; 27(4):241-6. PubMed ID: 6955937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal deoxynucleotidyl transferase activity in neoplastic and nonneoplastic hematopoietic cells.
    Bearman RM; Winberg CD; Maslow WC; Racklin B; Carlson F; Nathwani BN; Kim H; Diamond LW; Fallis B; Rappaport H
    Am J Clin Pathol; 1981 Jun; 75(6):794-802. PubMed ID: 7020399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terminal deoxynucleotidyl transferase, TdT, as a marker for leukemia and lymphoma cells.
    Campagnari F; Bombardieri E; de Braud F; Baldini L; Maiolo AT
    Int J Biol Markers; 1987; 2(1):31-42. PubMed ID: 3323341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal deoxynucleotidyl transferase.
    Hoffbrand AV; Janossy G
    Haematologica; 1978 Jun; 63(3):231-40. PubMed ID: 107062
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chromosome analysis and TdT determination: important prognostic parameters of blastic crises in chronic myelocytic leukemia].
    Schwarzmeier JD; Haas O; Paietta E; Fischer P
    Wien Klin Wochenschr; 1982 Oct; 94(19):514-20. PubMed ID: 6760560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of terminal deoxynucleotidyl transferase in patients with acute leukemia and malignant lymphoma: results obtained by immunofluorescence assay (author's transl)].
    Ho AD; Hunstein W; Uhl N; Storch HH
    Dtsch Med Wochenschr; 1981 May; 106(20):643-7. PubMed ID: 7014159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of leukemia cell terminal transferase measurements.
    McCaffrey R; Lillquist A; Sallan S; Cohen E; Osband M
    Cancer Res; 1981 Nov; 41(11 Pt 2):4814-20. PubMed ID: 7028251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous evaluation for terminal deoxynucleotidyl transferase and myeloperoxidase in leukemia.
    Folds JD; Bollum FJ; Dean L; Chan J; Stass SA
    Am J Hematol; 1982 Jun; 12(4):391-6. PubMed ID: 6287839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia cutis in blastic transformation of chronic myelocytic leukemia: TdT positive blasts and response to vincristine and prednisone.
    Ansell JE; Bhawan J; Pechet L
    J Cutan Pathol; 1980 Oct; 7(5):302-9. PubMed ID: 6933170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
    Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
    Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.